TSPAN2 and lung adenocarcinoma: Otsubo et al demonstrated that RNAi-mediated TSPAN2 knockdown decreases cell motility and invasive activity in small airway epithelial cells, the putative origin of lung adenocarcinomas, and promotes survival in metastatic mouse models (Otsubo et al, 2014).